# A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy

> **NCT00626639** · PHASE1,PHASE2 · COMPLETED · sponsor: **Swedish Orphan Biovitrum** · enrollment: 5 (actual)

## Conditions studied

- Mucositis
- Head and Neck Cancer

## Interventions

- **DRUG:** Placebo
- **DRUG:** palifermin
- **RADIATION:** Radiotherapy
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00626639
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-05
- **Final completion:** 2015-07
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00626639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00626639, "A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00626639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*